Collegium Pharmaceutical (COLL) Shares Outstanding (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Shares Outstanding (Entity) of $32.1 million for Q1 2026, up 0.92% year-over-year from $31.8 million in Q1 2025, and up 1.2% quarter-over-quarter from $31.7 million in Q4 2025.
Collegium Pharmaceutical (COLL) Shares Outstanding (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Shares Outstanding (Entity) history runs 13 years deep, the most recent figure standing at $32.1 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 0.92% year-over-year to $32.1 million; the TTM figure through Mar 2026 stood at $32.1 million (up 0.92% YoY), while the FY2025 annual figure was $31.7 million, down 1.76% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $32.1 million, up from $31.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $38.2 million in Q4 2023, with the low at $31.6 million in Q3 2025.
- The 5-year median for Shares Outstanding (Entity) is $32.4 million (2024), against an average of $34.5 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) rose 3.95% in 2023, then retreated 15.5% in 2024.
- Collegium Pharmaceutical's Shares Outstanding (Entity) stood at $37.1 million in 2022, then advanced by 2.99% to $38.2 million in 2023, then declined by 15.5% to $32.3 million in 2024, then retreated by 1.76% to $31.7 million in 2025, then gained by 1.2% to $32.1 million in 2026.
- Business Quant data shows COLL's Shares Outstanding (Entity) at $32.1 million in Q1 2026, $31.7 million in Q4 2025, and $31.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 832.44 Mn |
| 10 | Collegium Pharmaceutical | 899.49 Mn | 750.17 Mn | 110.29 Mn | 32.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.46 Mn |
| Mar 31, 2026 | 32.09 Mn |
| Dec 31, 2025 | 31.71 Mn |
| Sep 30, 2025 | 31.57 Mn |
| Jun 30, 2025 | 31.81 Mn |
| Mar 31, 2025 | 31.79 Mn |
| Dec 31, 2024 | 32.27 Mn |
| Sep 30, 2024 | 32.26 Mn |
| Jun 30, 2024 | 32.43 Mn |
| Mar 31, 2024 | 32.33 Mn |
| Dec 31, 2023 | 33.74 Mn |
| Sep 30, 2023 | 33.74 Mn |
| Jun 30, 2023 | 34.62 Mn |
| Mar 31, 2023 | 34.32 Mn |
| Dec 31, 2022 | 33.83 Mn |
| Sep 30, 2022 | 34.06 Mn |
| Jun 30, 2022 | 34.00 Mn |
| Mar 31, 2022 | 33.67 Mn |
| Dec 31, 2021 | 34.94 Mn |
| Sep 30, 2021 | 35.37 Mn |